Breaking News

Government on liver protection warpath

Rob @ July 8, 2009 # No Comment Yet

Back in May, Hydroxycut was nailed with a recall that sent the supplement market scrambling to make sure it didn’t fall under the ever inconsistent eye of the FDA. ┬áThe problem then was liver failure. A month later, the FDA launched another report that sent the over-the-counter market scrambling, but in a much different way.

Read the rest of this entry »